Abstract
A Phase I/II Study to Investigate the Safety and Clinical Activity of the Protein Arginine Methyltransferase 5 Inhibitor GSK3326595 in Subjects with Myelodysplastic Syndrome and Acute Myeloid Leukemia
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have